Device Longevity in Implantable Cardioverter-Defibrillator Therapy

Summary

Implantable cardioverter-defibrillators (ICDs) are critical for preventing sudden cardiac death in high-risk patients, yet their therapeutic value is closely tied to device longevity. Battery depletion and mechanical wear necessitate periodic generator replacement, which carries procedural risks, infection potential and increased health-care costs. Longevity is influenced by battery chemistry, device programming, pacing modes and energy requirements for therapy delivery. Technological innovations – including high-energy lithium-based chemistries, advanced power management algorithms and leadless sensing configurations – aim to extend service life while preserving therapeutic efficacy. Improvements in device design have progressively increased median battery life from under five years in early models to over ten years in many contemporary systems. Nevertheless, substantial variability remains across manufacturers and device types, and real-world performance data are essential for optimising device selection and follow-up strategies on a global scale.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Device Longevity in Implantable Cardioverter-Defibrillator Therapy publication trend

The graph below shows the total number of articles in device longevity in implantable cardioverter-defibrillator therapy across all publications each year (not limited to Nature Index journals).

Technical terms

Battery chemistry: The specific lithium-based composition (e.g., LiMnO₂, LiSVO/CFₓ) that determines energy density and discharge profile.

Elective Replacement Indicator (ERI): A device-generated alert signalling that battery voltage has fallen below a predefined threshold and generator replacement should be scheduled.

Cardiac resynchronization therapy defibrillator (CRT-D): A combined device providing both biventricular pacing to improve cardiac synchrony and defibrillation capability to terminate life-threatening arrhythmias.

References

  1. Longevity of implantable cardioverter defibrillators: a comparison among manufacturers and over time. EP Europace (2015).
  2. Reliability and longevity of implantable defibrillators. Journal of Interventional Cardiac Electrophysiology (2021).
  3. “Real-world” analysis of battery longevity of implantable cardioverter-defibrillators: an in-depth analysis of a prospective defibrillator database. BMC Cardiovascular Disorders (2023).
Nature Strategy Reports
Turn complex research questions into confident strategic decisions 

When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.

  • Benchmark your performance against global peers using robust, methodologically sound analysis.

  • Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.

  • Gain tailored, decision-ready recommendations aligned to your strategic priorities.

Talk to us to learn more about our data dashboards and bespoke strategy reports.

Nature Masterclasses
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.

Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:

  • Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.

  • Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.

  • Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.

Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.